tiprankstipranks
Trending News
More News >
Assertio Therapeutics Inc (ASRT)
NASDAQ:ASRT
US Market

Assertio Therapeutics (ASRT) Cash flow

Compare
1,157 Followers

Assertio Therapeutics Cash Flow

ASRT's free cash flow for Q3 2025 was $-4.77M. For the 2025 fiscal year, ASRT's free cash flow was decreased by $-22.57M and operating cash flow was $-4.77M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ 26.41M$ 49.60M$ 78.60M$ 5.52M$ -65.57M
Investing Cash Flow
$ -48.91M$ 3.10M$ -42.67M$ -18.52M$ 512.80M
Financing Cash Flow
$ -350.00K$ -44.20M$ -7.79M$ 29.03M$ -468.55M
End Cash Position
$ 50.59M$ 73.44M$ 64.94M$ 36.81M$ 20.79M
Free Cash Flow
$ 26.41M$ 48.98M$ 78.32M$ 5.47M$ -65.58M
Currency in USD

Assertio Therapeutics Cash Flow